claim
FMI

Teaching - Course details


Title Tuesday's growth control and cancer seminars
Location: FMI, Maulbeerstrasse 66, 4058 Basel Room 5.30 (unless otherwise indicated) Time: 12.15 h (with sandwiches)
Coordinator: Coordinator: Brian A. Hemmings FRS
 
Program
Sep 07, 2010 Fawaz Haj, University of California Davis, Calif., USA
Regulation by protein-tyrosine phosphatase
Oct 12, 2010 John Stingl, Cancer Research, Cambridge Research Institute, UK
Mammary stem and progenitor cells: Understanding the cellular context of breast tumours
Oct 13, 2010 Antonia Patsialou, Albert Einstein College of Medicine, Bronx, New York, USA
Gene expression profiles and mechanisms of invasion in breast cancer
Oct 26, 2010 Matt Smalley, Breast Cancer Centre/ Institute of Cancer Research, London, UK
Stem cell biology, molecular pathology and mouse genetics: a combinatorial approach to understanding the origins of breast cancer
Nov 02, 2010 Francesco Bertoni, Oncology Institute of Southern Switzerland (IOSI), Lugano
Genomic profiling in diffuse large B cell lymphomas
Nov 09, 2010 Tatjana Petrova, University of Lausanne
Cancer-specific vs developmental transcriptional programs in colon tumorigenesis
Nov 23, 2010 Christoph Klein, Department of Pathology Division of Oncogenomics, University of Regensburg, Germany
The metastatic progression of solid cancers: Insights from the analysis of disseminated tumour cells
Nov 30, 2010 Adrian Ochsenbein, University of Berne
Immunosurveillance of leukemia stem cells
Dec 06, 2010 Michael Eck, Dana-Farber Cancer Institute, Boston, MA, USA
Understanding and rationally targeting EGFR-mutant lung cancer
Dec 14, 2010 Cathrin Brisken, EPFL, Lausanne
Genetic dissection of signaling pathways in breast development and cancer
Jan 11, 2011 Elke Ober, MRC, National Institute for Medical Research, London, UK)
Liver organogenesis in zebrafish
Feb 08, 2011 Eric Sahai, Cancer Research UK, London, UK
Imaging the metastatic process
Feb 10, 2011 Marcelo Kazanietz, University of Pennsylvania, Philadelphia, USA
Diacylglycerol and Rac signaling in cancer: old friends and new foes
Feb 21, 2011 Timm Schröder, Helmholtz Zentrum, Munich, Germany
Tracking stem cells at the single cell level: New tools for old questions
Feb 22, 2011 L.H.F Mullenders, LUMC, Department of Toxicogenetics, Leiden, The Netherlands
Nucleotide excision repair: complex assembly and its regulation
Mar 03, 2011 Nick Tonks, Cold Spring Harbor Laboratory, Laurel Hollow, NY, USA
Targeting the reversibly oxidized protein tyrosine phosphatase superfamily
Mar 08, 2011 Kurt Ballmer, Paul Scherrer Institut, Villigen
Activation, intracellular trafficking, and signaling by VEGF receptor 2; How structural insights promote the development of new receptor inhibitory drugs
Mar 22, 2011 Clare Isacke, Breakthrough Breast Cancer Research Centre , London, UK
Tumour angiogenesis and tumour cell extravasation
Mar 29, 2011 Jason Caroll, Cancer Research UK Cambridge Research Institute, UK
Mechanisms of estrogen receptor transcription in breast cancer
Apr 12, 2011 Joaquin Arribas, Vall d'Hebron University Hospital, Barcelona, Spain
The HER2/ErbB2 receptor and breast cancer stratification
Apr 19, 2011 Curzio Rüegg, University of Fribourg
Radiotherapy-induced modifications of the tumor microenvironment promote tumor metastasis
May 03, 2011 Phil Jones, Hutchison-MRC Research Centre, Cambridge, UK
Stochastic cell fate in normal and preneoplastic epithelial progenitor cells
May 10, 2011 Barry Gusterson, University of Glasgow, Scotland
The normal breast. Contorversies and insights into cancer progression?
May 17, 2011 Nic Tapon, London Research Institute, London, UK
Control of tissue growth by the Hippo signalling pathway in Drosophila
May 23, 2011 Mirela Delibegovic, University of Aberdeen, Scotland
Exceptionally on Monday/ Role of PTP1B in inflammation, obesity, diabetes and cardiovascular function
Jan 24, 2012 Dr. Christina Scheel, Whitehead Institute for Biomedical Research, Cambridge, MA, USA
Autocrine and paracrine signals induce and maintain mesenchymal and stem-cell states in the breast
Feb 21, 2012 Prof. Dr. Amparo Acker -Palmer Molecular and Cellular Neurobiology Institute of Cell Biology and Neuroscience, Biologicum and Neuro and Vascular Development Frankfurt Institute for Molecular Life Sciences, Goethe University Frankfurt Germany
Mechanisms of tumor invasion and evasive resistance to anti-angiogenesis therapy
Feb 23, 2012 Peter Sicinski, Dana-Farber Cancer Institute, Dept. of Cancer Biology, Boston, USA
Cell Cycle Machinery in Mouse Development and in Cancer
Mar 12, 2012 Ali Badache, Centre de Recherche en Cancerologie de Marseille, Institut Paoli-Calmettes, MARSEILLE
ErbB2 signaling to microtubule capture and directed cell motility
Mar 20, 2012 Cora-Ann Schoenenberger, Biozentrum, University of Basel
Imprints of tumor progression on the nanomechanics of cells and tissues
Mar 27, 2012 Dr. Roger David John Pocock, KÝbenhavns Universitet, BRIC, KÝbenhavn, Danmark
Gene regulatory logic of sensory neuron specification
Mar 28, 2012 Stefano Piccolo, Universitŗ di Padova, Dipartimento di Biotecnologie Mediche, Padova, Italy
Role of the Hippo pathway effectors YAP and TAZ in mechanotransduction, cell polarity and cancer stem cells
Apr 17, 2012 Christian Ruiz, Institute for Pathology, University Hospital, Basel
TBA
May 08, 2012 Valeria Poli, Department of Genetics, Biology and Biochemistry, Torino, Italy
TBA
May 15, 2012 Thomas Brabletz, University of Freiburg Medical Center, Dept. of Visceral Surgery, Germany
TBA
May 22, 2012 Coya Tapia, Institut für Pathologie, Bern
TBA
May 29, 2012 David Adams, The Wellcome Trust Sanger Institute, London, UK
TBA
About this site2018 © FMI Basel Switzerland